BioMarin off after earnings, guidance

BioMarin (NASDAQ:BMRN) fell $5.65 (32%) to $12.04 on Thursday after reporting 4Q08 and

Read the full 130 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE